These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16712610)

  • 21. Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow.
    Misawa M; Kai S; Okada M; Nakajima T; Nomura K; Wakae T; Toda A; Itoi H; Takatsuka H; Itsukuma T; Nishioka K; Fujimori Y; Ogawa H; Hara H
    Int J Hematol; 2006 Jan; 83(1):74-9. PubMed ID: 16443557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced-intensity conditioning in unrelated donor cord blood transplantation for familial hemophagocytic lymphohistiocytosis.
    Nishi M; Nishimura R; Suzuki N; Sawada A; Okamura T; Fujita N; Kanai R; Yano J; Adachi S; Yasumi T; Sato E; Yasutomo K; Ishii E; Ohga S
    Am J Hematol; 2012 Jun; 87(6):637-9. PubMed ID: 22488407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Umbilical cord blood stem cells transplantation from an unrelated donor into an adult with severe aplastic anemia].
    Mao P; Liao C; Zhu Z; Wang H; Wang S; Mo W; Ying Y; Li Q; Liu B
    Zhonghua Xue Ye Xue Za Zhi; 2000 Oct; 21(10):533-6. PubMed ID: 11877033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility and results of bone marrow transplantation from an HLA-mismatched unrelated donor for children and young adults with acquired severe aplastic anemia.
    Yagasaki H; Takahashi Y; Kudo K; Ohashi H; Hama A; Yamamoto T; Tanaka M; Yoshida N; Hidaka H; Nishio N; Kojima S
    Int J Hematol; 2007 Jun; 85(5):437-42. PubMed ID: 17562622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Unrelated cord blood transplantation in a child with very severe aplastic anemia].
    Yasui N; Koh K; Park MJ; Kato M; Mori M; Akiyama K; Seki M; Takahashi H; Hanada R
    Rinsho Ketsueki; 2012 Dec; 53(12):1997-2002. PubMed ID: 23318965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
    Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
    Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman-Diamond syndrome.
    Sauer M; Zeidler C; Meissner B; Rehe K; Hanke A; Welte K; Lohse P; Sykora KW
    Bone Marrow Transplant; 2007 Feb; 39(3):143-7. PubMed ID: 17211437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stable mixed chimerism without relapse after related allogeneic umbilical cord blood transplantation in a child with severe aplastic anemia.
    Boiron JM; Cotterêt S; Cony-Makhoul P; Merel P; Micheau M; Perel Y; Belloc F; Bernard P; Reiffers J
    Bone Marrow Transplant; 1998 Oct; 22(8):819-21. PubMed ID: 9827983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing 3 Gy of total body irradiation, cyclophosphamide with or without antithymocyte globulin.
    Inagaki J; Nagatoshi Y; Kawano Y; Saito Y; Takahashi D; Nagayama J; Shinkoda Y; Hirata H; Okamura J
    Pediatr Transplant; 2007 Mar; 11(2):180-6. PubMed ID: 17300498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful unrelated umbilical cord blood transplantation in children with Shwachman-Diamond syndrome.
    Vibhakar R; Radhi M; Rumelhart S; Tatman D; Goldman F
    Bone Marrow Transplant; 2005 Nov; 36(10):855-61. PubMed ID: 16113664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful umbilical cord blood transplantation for severe chronic active Epstein-Barr virus infection after the double failure of hematopoietic stem cell transplantation.
    Ishimura M; Ohga S; Nomura A; Toubo T; Morihana E; Saito Y; Nishio H; Ide M; Takada H; Hara T
    Am J Hematol; 2005 Nov; 80(3):207-12. PubMed ID: 16247742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.
    Lawler M; McCann SR; Marsh JC; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socié G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A;
    Br J Haematol; 2009 Mar; 144(6):933-45. PubMed ID: 19183198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced-intensity conditioning regimen using low-dose total body irradiation before allogeneic transplant for hematologic malignancies: Experience from the European Group for Blood and Marrow Transplantation.
    Belkacémi Y; Labopin M; Hennequin C; Hoffstetter S; Mungai R; Wygoda M; Lundell M; Finke J; Aktinson C; Lorchel F; Durdux C; Basara N
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):544-51. PubMed ID: 17141976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperacute graft-vs.-host disease after related HLA-identical umbilical cord blood transplantation.
    Kuskonmaz B; Gocer S; Ersoy-Ewans S; Cetin Ozman F; Cetin M; Uckan D
    Pediatr Transplant; 2007 Nov; 11(7):818-20. PubMed ID: 17910666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
    Lee KH; Lee JH; Lee JH; Kim DY; Kim SH; Shin HJ; Lee YS; Kang YA; Seol M; Ryu SG
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):61-72. PubMed ID: 19135944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes of unrelated donor umbilical cord blood transplantation for 30 adults with hematological malignancies.
    Kobayashi K; Maeda Y; Hara Y; Nishie-Kataoka M; Nishimori H; Sugiyama H; Namba N; Kubonishi S; Niiya M; Shinagawa K; Ikeda K; Tanimoto M
    Anticancer Res; 2009 May; 29(5):1763-70. PubMed ID: 19443401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients.
    Lang P; Mueller I; Greil J; Bader P; Schumm M; Pfeiffer M; Hoelle W; Klingebiel T; Heinzelmann F; Belka C; Schlegel PG; Kremens B; Woessmann W; Handgretinger R
    Blood Cells Mol Dis; 2008; 40(1):33-9. PubMed ID: 17884640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.